Sysmex Corporation ADR (OTCMKTS:SSMXY) Short Interest Update

Key Points

• Sysmex Corporation experienced a significant decline in short interest, dropping 91.9% from 91,200 shares to 7,400 shares as of July 31st.
• The company's stock price was reported at $13.42, with a 12-month high of $22.00 and a low of $13.42, reflecting a challenging trading environment.
• In its latest quarterly earnings, Sysmex reported an EPS of $0.05, missing the consensus estimate by $0.07, while revenue reached $717.09 million, below expectations.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totaling 7,400 shares, adecreaseof91.9% from the July 15th total of 91,200 shares. Based on an average daily trading volume, of 216,500 shares, the short-interest ratio is currently 0.0 days. Approximately0.0% of the company's shares are sold short. Approximately0.0% of the company's shares are sold short. Based on an average daily trading volume, of 216,500 shares, the short-interest ratio is currently 0.0 days.

Sysmex Stock Up 0.3%

Sysmex stock traded up $0.04 during mid-day trading on Tuesday, reaching $13.37. The company's stock had a trading volume of 223,253 shares, compared to its average volume of 80,008. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.30 and a current ratio of 2.97. Sysmex has a 12 month low of $13.31 and a 12 month high of $22.00. The business's 50 day simple moving average is $16.28 and its 200 day simple moving average is $17.48. The company has a market capitalization of $8.42 billion, a price-to-earnings ratio of 26.74 and a beta of 1.15.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.07). Sysmex had a net margin of 9.35% and a return on equity of 10.36%. The company had revenue of $717.09 million during the quarter, compared to analyst estimates of $807.27 million. As a group, research analysts anticipate that Sysmex will post 0.57 earnings per share for the current year.

Analyst Ratings Changes

Separately, Zacks Research upgraded Sysmex from a "strong sell" rating to a "hold" rating in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.